Unsung Hero: Dr. Tatsuya Kondo
One year ago, we featured Dr. Tatsuya Kondo on the cover of The ACCJ Journal. The American Chamber of Commerce in Japan (ACCJ) had recognized him for his contributions to the healthcare industry with the 2020 ACCJ Outstanding Achievement Award. Dr. Kondo played a key role in Japan’s healthcare efforts as chief executive of the Pharmaceuticals and Medical Devices Agency (PMDA) from 2008 to 2019. Sadly, he passed away on September 26 after a battle with prostate cancer. ACCJ members shared thoughts and memories with The ACCJ Journal about what Dr. Kondo meant to them and the industry.
Remembering the former PMDA chief executive and how he changed medicine in Japan
One year ago, we featured Dr. Tatsuya Kondo on the cover of The ACCJ Journal. The American Chamber of Commerce in Japan (ACCJ) had recognized him for his contributions to the healthcare industry with the 2020 ACCJ Outstanding Achievement Award. Dr. Kondo played a key role in Japan’s healthcare efforts as chief executive of the Pharmaceuticals and Medical Devices Agency (PMDA) from 2008 to 2019. Sadly, he passed away on September 26 after a battle with prostate cancer. ACCJ members shared thoughts and memories with The ACCJ Journal about what Dr. Kondo meant to them and the industry.
Strong Supporter
“We are all deeply shocked and saddened to hear the news of Dr. Kondo’s passing and would like to extend our deepest condolences to his family,” said Zimmer Biomet G.K. Executive Officer and Chairman Kazuya Ogawa, who is also chairperson of the American Medical Devices and Diagnostics Manufacturers’ Association (AMDD), adding that the AMDD Executive Committee offered a silent prayer for his soul at its October meeting.
“Dr. Kondo was respected as a strong supporter of the need to resolve the medical device lag issues. His thoughtful, sharply focused actions, always led to a quick resolution of serious lag problems. I personally recall intense discussions with him about more than 300 files of outstanding orthopedic reviews on hand at the PMDA, just as some 100 new applications were coming in. He promptly organized a task force to tackle the issues and cleaned them up in a very short time frame. He demonstrated great leadership during his time at the PMDA, and we feel very honored to have had opportunities to work with him.”
Man of Results
ACCJ Governor James Feliciano, who serves as chair of the Japan-based Executive Committee of the Pharmaceutical Research and Manufacturers of America, highlighted some of the results.
“Dr. Kondo was nothing short of a Japanese hero. Through his untiring efforts over so many years, he transformed the PMDA into a premier regulatory review and approval body,” he said. “We can look at the results in terms of months of review, number of new products approved, or the elimination of the drug lag compared with Western countries. However, the real measurement should be the number of Japanese patients who received access to lifesaving and life-changing innovative pharmaceutical medicine. Kondo-san is the unsung hero for so many patients in Japan.”
Leader of Change
Simone Thomsen, president and general manager of Eli Lilly Japan K.K. and ACCJ governor–Kansai, praised his leadership.
“We would like to express our deepest sympathy on the passing of Dr. Tatsuya Kondo, chief executive emeritus of the PMDA. He was truly a great leader for Japan who advanced our efforts to eliminate the drug lag for Japanese patients,” she said.
“Under Dr. Kondo’s leadership, regulatory science was truly developed and incorporated into the PMDA’s review, which yielded greater transparency for the industry. We appreciate the opportunity to have had the chance to work with him.”
Warm and Supportive
ACCJ Vice President and former PhRMA Japan Representative Amy Jackson, who is APAC senior director of government affairs and policy at Janssen Pharmaceutical K.K., said: “Dr. Kondo had a powerful and long-term impact on the Japanese healthcare system. Countless Japanese patients got early access to needed, lifesaving medicines thanks to his vision and efforts to make the PMDA a truly world-class regulatory system. Not only was Dr. Kondo a great leader, he was also an excellent ambassador between the PMDA and international stakeholders. I so fondly remember the many times PhRMA had meetings with him and his team. Dr. Kondo would always walk into the PMDA conference room with a big smile on his face. He would greet his international visitors with great warmth and would earnestly urge them to share, without reservation, any comments or concerns they had about the Japanese regulatory system. He will be greatly missed.”
Thank You
ACCJ Healthcare Committee Co-chair John Carlson summed up Dr. Kondo’s support of the chamber. “He was no stranger at the ACCJ. During the course of his career at the PMDA, he visited the chamber on numerous occasions to share his thoughts on the future of the agency and exchange opinions with members of the Healthcare Committee," he recalled. “His commitment to public–private partnership was compelling. The ACCJ extends its deepest gratitude to Dr. Kondo and condolences to his family. He was a transformational healthcare leader.”
Robert “Skipp” Orr (1953–2021)
The American Chamber of Commerce in Japan (ACCJ) has lost a longtime member and leader, Robert “Skipp” Orr, who passed away on August 12 due to heart failure at his home in Kamakura. He was 68. Orr played a key role in US–Japan relations over many decades and helped lead the ACCJ during the 1990s as a governor (1995–96) and vice president (1997–99). He guided Boeing Japan K.K. as president from 2002 to 2007 and served as chairman of the board of the Panasonic Foundation from 2007 to 2010.
Former ACCJ leader and US Ambassador passes away at the age of 68
The American Chamber of Commerce in Japan (ACCJ) has lost a longtime member and leader, Robert “Skipp” Orr, who passed away on August 12 due to heart failure at his home in Kamakura. He was 68.
Orr played a key role in US–Japan relations over many decades and helped lead the ACCJ during the 1990s as a governor (1995–96) and vice president (1997–99). He guided Boeing Japan K.K. as president from 2002 to 2007 and served as chairman of the board of the Panasonic Foundation from 2007 to 2010.
In September 2010, he was named US Ambassador to the Asian Development Bank (ADB) and held the post until December 31, 2015. He continued to serve as a member of the ADB Institute Advisory Council following his ambassadorship.
Orr’s contributions to US–Japan relations were recognized by the Japanese government in 2018 with the Order of the Rising Sun, Gold Rays with Rosette.
Memories
During his time as an ACCJ leader, Orr often wrote columns for The ACCJ Journal. We asked some members who worked alongside Orr at the chamber for their memories.
ACCJ Chairman Emeritus Kumi Sato said that “Skipp was the kind of person who, the longer you knew him, the more you found out about his depth of knowledge and expertise, and his life. He knew what he was talking about.
“He devoted his life to improving US relations with Asian countries,” she continued. “It seemed like he loved his job, and had a strong sense of duty to let everyone understand the challenges and sensitivities of these relationships. He cared. I’m so saddened that he went too early and fast, and wish that we could have had more chats, to find out what he thinks of the world today.”
President emeritus Tom Whitson remembers Orr as “a longtime friend and ACCJ colleague who enjoyed life and could laugh at himself. He didn’t mind being teased as ‘Mr. Ambassador’ for his position with the Asian Bank in Manila. As an ACCJ vice president, Skipp’s knowledge of US–Japan trade policy and policymakers was very valuable to the chamber. He had a fascinating career in politics, academia, industry, and with international organizations. I appreciated his willingness to share what he knew with people less well-connected than he was, like me.”
Glen Fukushima fondly remembers working together with Orr. “Skipp and I were friends from the 1980s, and we had a lot of fun in the 1990s when I was ACCJ president and he was one of the vice presidents,” he recalled. “We worked especially closely with Ambassador Walter Mondale (1993–96) and Ambassador Tom Foley (1997–2001) on US–Japan trade issues, since Skipp was working for Motorola and I was working for AT&T. He later worked for Boeing and I worked for Airbus, but we always maintained our friendship. We had a Zoom call in April and exchanged emails in early August, only a week before he passed away. I will really miss his great friendship.”
Former ACCJ executive director Samuel Kidder said: “I first got to know Skipp Orr when working on telecom market access decades ago—Skipp at Motorola, me at the US Embassy in Tokyo. Through his years at Boeing, and then as Ambassador at the Asian Development Bank, our paths often crossed or converged. It was a privilege to be on the same team with him so often. His open friendship and broad intellectual curiosity made him a special colleague. So many of us will miss and long remember Skipp.”
And Don Kanak, who served as ACCJ president in 2002 and chairman in 2003, told The ACCJ Journal that he was shocked and saddened to learn of Orr’s passing. “I met Skipp in Japan many years ago, in Tokyo, when he was representing Motorola and then heading Boeing, and I was with AIG,” he said. “We collaborated on a number of ACCJ initiatives related to high-profile US–Japan trade issues.
“Skipp was an excellent strategist on trade and political economy and a joy to work with. He had an exceptional understanding of the value of long-term relationships in Japan, the United States, and Europe. Not everyone knew Skipp’s background included a deep knowledge of Europe and native German language skills, in addition to Japanese,” Kanak continued.
“More recently, I was able to connect with Skipp while he served with distinction as the US Ambassador to the Asian Development Bank, playing a big role building multilateral support for infrastructure in Southeast Asia and for sustainability. He was an extraordinary person and a good friend. We will all miss him greatly.”